ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema

ClinicalTrials.gov ID: NCT02699450

Public ClinicalTrials.gov record NCT02699450. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multiple-Center, Multiple-Dose, Randomized, Active Comparator-Controlled, Double-Masked, Parallel Group, 36-Week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema

Study identification

NCT ID
NCT02699450
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
229 participants

Conditions and interventions

Interventions

  • Faricimab Drug
  • Ranibizumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 26, 2016
Primary completion
Sep 14, 2017
Completion
Dec 13, 2017
Last update posted
Sep 24, 2020

2016 – 2017

United States locations

U.S. sites
60
U.S. states
26
U.S. cities
56
Facility City State ZIP Site status
Retinal Research Institute, LLC Phoenix Arizona 85014
Associated Retina Consultants Phoenix Arizona 85020
Arizona Retina and Vitreous Consultants Phoenix Arizona 85021
Retina Associates Southwest PC Tucson Arizona 85750
Retina Consultants of Orange County Fullerton California 92835
United Med Res Inst Inglewood California 90301
Northern California Retina Vitreous Associates Mountain View California 94040
Ophthalmic Clinical Trials San Diego Oceanside California 92056
Southern CA Desert Retina Cons Palm Desert California 92211
Retina Consultants, San Diego Poway California 92064
Retinal Consultants Med Group Sacramento California 95825
California Retina Consultants Santa Barbara California 93103
Bay Area Retina Associates Walnut Creek California 94598
Retina Consultants of Southern Colorado Springs Colorado 80909
Rand Eye Deerfield Beach Florida 33064
National Ophthalmic Research Institute Fort Myers Florida 33912
Florida Eye Associates Melbourne Florida 32901
Retina Specialty Institute Pensacola Florida 32503
Retina Vitreous Assoc of FL St. Petersburg Florida 33711
Southern Vitreoretinal Assoc Tallahassee Florida 32308
Southeast Retina Center Augusta Georgia 30909
Georgia Retina PC Marietta Georgia 30060
Univ of Illinois at Chicago Chicago Illinois 60612
University Retina and Macula Associates, PC Oak Forest Illinois 60452
Illinois Retina Associates SC Oak Park Illinois 60304
Midwest Eye Institute Indianapolis Indiana 46290
Wolfe Eye Clinic West Des Moines Iowa 50266
Retina Associates of Kentucky Lexington Kentucky 40509
Paducah Retinal Center Paducah Kentucky 42001
Wilmer Eye Institute Baltimore Maryland 21287
Vitreo-Retinal Associates Grand Rapids Michigan 49546
Vitreoretinal Surgery Edina Minnesota 55435
Sierra Eye Associates Reno Nevada 89502
Retina Center of New Jersey Bloomfield New Jersey 07003
Eye Associates of New Mexico Albuquerque New Mexico 87102
University of New Mexico Albuquerque New Mexico 87131
Capital Region Retina Albany New York 12206
Opthalmic Consultants of LI Lynbrook New York 11563
Retina Consultants of Western New York Orchard Park New York 14127
Western Carolina Retinal Associate PA Asheville North Carolina 28803
Char Eye Ear &Throat Assoc Charlotte North Carolina 28210
Cleveland Clinic Foundation; Cole Eye Institute Cleveland Ohio 44195
OSU Eye Physicians & Surgeons Columbus Ohio 43212
Oregon Retina, LLP Eugene Oregon 97401
Retina Northwest Portland Oregon 97221
Palmetto Retina Center Florence South Carolina 29501
Charleston Neuroscience Inst Ladson South Carolina 29456
Charles Retina Institute Germantown Tennessee 38138
Tennessee Retina PC. Nashville Tennessee 37203
W Texas Retina Consultants PA Abilene Texas 79606
Austin Retina Associates Austin Texas 78705
Retina Consultants of Austin Austin Texas 78705
Retina Specialists DeSoto Texas 75115
Retina Consultants of Houston Houston Texas 77030
Med Center Ophthalmology Assoc San Antonio Texas 78240
Retina Consultants of Houston The Woodlands Texas 77384
Retina Associates of Utah Salt Lake City Utah 84107
Univ of Virginia Ophthalmology Charlottesville Virginia 22903
Spokane Eye Clinical Research Spokane Washington 99204
West Virginia University Eye Institute Morgantown West Virginia 26506

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02699450, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 24, 2020 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02699450 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →